innoscripta SE/€1INN
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About innoscripta SE
Innoscripta SE is a German software company specializing in cloud-based compliance solutions for research and development (R&D) tax credits and project management. Its primary product is a Software-as-a-Service (SaaS) platform that digitizes R&D workflows, assisting companies in identifying, validating, and managing R&D projects while ensuring compliant documentation for tax incentives. Founded in 2012 and headquartered in Munich, Germany, Innoscripta serves over 2,000 clients across more than twenty industries. The company operates on multi-year exclusive contracts, typically around three years, with most automatically renewed, generating revenue through commissions based on a percentage of clients' recoverable R&D costs. Innoscripta's scalable platform is designed for easy adoption across various countries and industries, supporting its growth strategy focused on international expansion and product development. (,)
- Ticker
- €1INN
- Sector
- Software & Cloud Services
- Primary listing
- XETRA
- Employees
- 396
- Headquarters
- Munich, Germany
- Website
- www.innoscripta.com
innoscripta SE Metrics
BasicAdvanced
€470M
9.20
€5.13
-
€4.00
8.48%
Price and volume
Market cap
€470M
52-week high
€112.60
52-week low
€42.70
Average daily volume
32K
Dividend rate
€4.00
Financial strength
Current ratio
2.447
Quick ratio
2.31
Long term debt to equity
0.295
Total debt to equity
0.304
Dividend payout ratio (TTM)
78.01%
Interest coverage (TTM)
381.19%
Profitability
EBITDA (TTM)
75.844
Gross margin (TTM)
72.01%
Net profit margin (TTM)
41.89%
Operating margin (TTM)
61.72%
Effective tax rate (TTM)
32.39%
Revenue per employee (TTM)
€310,000
Management effectiveness
Return on assets (TTM)
66.88%
Return on equity (TTM)
156.46%
Valuation
Price to earnings (TTM)
9.2
Price to revenue (TTM)
3.854
Price to book
12.25
Price to tangible book (TTM)
12.26
Price to free cash flow (TTM)
10.785
Free cash flow yield (TTM)
9.27%
Free cash flow per share (TTM)
4.374
Dividend yield (TTM)
8.48%
Forward dividend yield
8.48%
Growth
Revenue change (TTM)
42.47%
Earnings per share change (TTM)
51.10%
What the Analysts think about innoscripta SE
Analyst ratings (Buy, Hold, Sell) for innoscripta SE stock.
Analyst projections of the future price of innoscripta SE stock.
Bulls say / Bears say
In the first half of 2026, revenue rose 43% to €63.1 million and adjusted EBIT increased 49% to €36.4 million. Management reaffirmed full-year targets of at least €140 million in revenue and €80 million in EBIT. (innoscripta Investor Relations)
Germany increased the R&D tax allowance assessment base from €10 million to €12 million and added a 20% flat-rate surcharge on eligible costs in 2026. If this makes the scheme more attractive to businesses, it could support demand in innoscripta’s core market. (innoscripta Investor Relations)
Clusterix is now used by customers in 14 countries, with new clients reported across several European markets. This early international reach gives innoscripta room to grow beyond its German base. (Deutsche Börse)
Authorities searched innoscripta’s premises in an investigation into suspected assistance with unjustified tax benefits on some client applications. The company said the allegations and any financial or other consequences could not yet be assessed conclusively. (EQS News)
The company has commissioned separate external reviews of the alleged events and of Clusterix’s organisational and software-based controls. Findings that expose control weaknesses could undermine confidence in a platform whose role is to support tax-credit documentation. (Deutsche Börse)
A software migration delayed submissions and affected the timing of revenue in the second quarter. It shows that platform changes can disrupt the flow of work and make quarterly performance less predictable. (StockAnalysis)
Data summarised monthly by Lightyear AI. Last updated on 28 Oct 2026.
innoscripta SE Financial Performance
Revenues and expenses
innoscripta SE Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.